Yabao Pharmaceutical Group Co Ltd (600351) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.047x

Based on the latest financial reports, Yabao Pharmaceutical Group Co Ltd (600351) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥129.49 Million ≈ $18.95 Million USD) by net assets (CN¥2.76 Billion ≈ $403.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Yabao Pharmaceutical Group Co Ltd to measure how many days the company can operate on defensive assets alone.

Yabao Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Yabao Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yabao Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yabao Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jiangsu Bioperfectus Technologies Co Ltd SHG:688399	0.007x
Sturm Ruger & Company Inc NYSE:RGR	0.046x
Shanghai Rongtai Health Tech SHG:603579	-0.006x
Amata Corporation Public Company Limited BK:AMATA-R	0.062x
IFE Elevators Co Ltd SHE:002774	0.051x
Grupo KUO S.A.B. de C.V MX:KUOB	0.005x
Farglory FTZ Investment Holding Co Ltd TW:5607	0.041x
Tesna Inc KQ:131970	0.087x

Annual Cash Flow Conversion Efficiency for Yabao Pharmaceutical Group Co Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see 600351 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.89 Billion ≈ $423.62 Million	CN¥471.69 Million ≈ $69.02 Million	0.163x	-1.98%
2023-12-31	CN¥2.99 Billion ≈ $438.01 Million	CN¥497.55 Million ≈ $72.81 Million	0.166x	+8.54%
2022-12-31	CN¥3.01 Billion ≈ $439.97 Million	CN¥460.46 Million ≈ $67.38 Million	0.153x	+3.74%
2021-12-31	CN¥2.96 Billion ≈ $433.67 Million	CN¥437.50 Million ≈ $64.02 Million	0.148x	+9.21%
2020-12-31	CN¥2.82 Billion ≈ $412.41 Million	CN¥380.96 Million ≈ $55.75 Million	0.135x	-13.38%
2019-12-31	CN¥2.72 Billion ≈ $398.67 Million	CN¥425.17 Million ≈ $62.22 Million	0.156x	+10.21%
2018-12-31	CN¥3.01 Billion ≈ $440.86 Million	CN¥426.60 Million ≈ $62.43 Million	0.142x	+155.17%
2017-12-31	CN¥2.91 Billion ≈ $426.47 Million	CN¥161.73 Million ≈ $23.67 Million	0.055x	-2.85%
2016-12-31	CN¥2.73 Billion ≈ $399.54 Million	CN¥155.95 Million ≈ $22.82 Million	0.057x	+6.62%
2015-12-31	CN¥2.68 Billion ≈ $391.88 Million	CN¥143.47 Million ≈ $20.99 Million	0.054x	-45.42%
2014-12-31	CN¥1.82 Billion ≈ $266.31 Million	CN¥178.63 Million ≈ $26.14 Million	0.098x	+193.10%
2013-12-31	CN¥1.70 Billion ≈ $248.21 Million	CN¥56.80 Million ≈ $8.31 Million	0.033x	+155.92%
2012-12-31	CN¥1.62 Billion ≈ $236.39 Million	CN¥-96.73 Million ≈ $-14.15 Million	-0.060x	-270.37%
2011-12-31	CN¥1.16 Billion ≈ $169.56 Million	CN¥40.73 Million ≈ $5.96 Million	0.035x	+89.80%
2010-12-31	CN¥1.00 Billion ≈ $146.71 Million	CN¥18.57 Million ≈ $2.72 Million	0.019x	-95.48%
2009-12-31	CN¥899.55 Million ≈ $131.63 Million	CN¥368.56 Million ≈ $53.93 Million	0.410x	+230.61%
2008-12-31	CN¥830.32 Million ≈ $121.50 Million	CN¥102.90 Million ≈ $15.06 Million	0.124x	-55.43%
2007-12-31	CN¥380.08 Million ≈ $55.62 Million	CN¥105.69 Million ≈ $15.47 Million	0.278x	+702.54%
2006-12-31	CN¥334.54 Million ≈ $48.95 Million	CN¥11.59 Million ≈ $1.70 Million	0.035x	-53.49%
2005-12-31	CN¥354.37 Million ≈ $51.86 Million	CN¥26.40 Million ≈ $3.86 Million	0.074x	-68.41%
2004-12-31	CN¥338.16 Million ≈ $49.48 Million	CN¥79.73 Million ≈ $11.67 Million	0.236x	+879.94%
2003-12-31	CN¥318.26 Million ≈ $46.57 Million	CN¥-9.62 Million ≈ $-1.41 Million	-0.030x	-134.57%
2002-12-31	CN¥277.81 Million ≈ $40.65 Million	CN¥24.29 Million ≈ $3.55 Million	0.087x	-65.96%
2001-12-31	CN¥91.84 Million ≈ $13.44 Million	CN¥23.59 Million ≈ $3.45 Million	0.257x	--

About Yabao Pharmaceutical Group Co Ltd

SHG:600351 China Drug Manufacturers - Specialty & Generic

Market Cap

$605.54 Million

CN¥4.14 Billion CNY

Market Cap Rank

#11421 Global

#3267 in China

Share Price

CN¥5.98

Change (1 day)

-0.99%

52-Week Range

CN¥5.98 - CN¥8.01

All Time High

CN¥14.53